Edward L. Mattiuz - Concepedia

Author

Edward L. Mattiuz

Eli Lilly (United States)

Also Known As

E L Mattiuz, E Mattiuz, E.L. Mattiuz, Edward L Mattiuz, Edward L. Mattiuz, Edward Mattiuz

Publications

903

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)Eli Lilly (Spain)

About

Edward L. Mattiuz is an author at Eli Lilly (United States) specializing in pharmacology, medicine, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	483
2	Biochemistry	3	3	131
3	Natural Sciences	2	2	93
4	Social Sciences	2	2	265
5	Health Sciences	1	1	38

Edward L. Mattiuz

Publications

878

Citations

H-Index

Page 1

	Year	Citations
Disposition and biotransformation of the antipsychotic agent olanzapine in humans. Kelem Kassahun, Edward L. Mattiuz, Eldon H. Nyhart, PubMed Plasma CompartmentPsychotropic MedicationPsychopharmacologyPharmacotherapySocial Sciences	1997	212
Disposition and Metabolic Fate of Atomoxetine Hydrochloride: The Role of CYP2D6 in Human Disposition and Metabolism John‐Michael Sauer, G. Douglas Ponsler, Edward L. Mattiuz, Drug Metabolism and Disposition	2003	150
Pharmacological Characterization of the Competitive GLUK5 Receptor Antagonist Decahydroisoquinoline LY466195 in Vitro and in Vivo Brianne Weiss, Andrew Alt, Ann Marie L. Ogden, Journal of Pharmacology and Experimental Therapeutics	2006	74
SELECTIVE REDUCTION OF N-OXIDES TO AMINES: APPLICATION TO DRUG METABOLISM Palaniappan Kulanthaivel, Robert J. Barbuch, Rita S. Davidson, Drug Metabolism and Disposition	2004	54
Disposition and metabolism of olanzapine in mice, dogs, and rhesus monkeys. Edward L. Mattiuz, Ronald B. Franklin, Todd A. Gillespie, PubMed Molecular PharmacologyPharmacological StudyRhesus MonkeysMedicinePsychotropic Medication	1997	53
Ethyl (3<i>S</i>,4a<i>R</i>,6<i>S</i>,8a<i>R</i>)-6-(4-Ethoxycar- bonylimidazol-1-ylmethyl)decahydroiso- quinoline-3-carboxylic Ester: A Prodrug of a GluR5 Kainate Receptor Antagonist Active in Two Animal Models of Acute Migraine Sandra Filla, Mark A. Winter, Kirk W. Johnson, Journal of Medicinal Chemistry Diethyl EsterPharmacotherapyExperimental Pharmacology4-Ethoxycar- Bonylimidazol-1-ylmethylMolecular Pharmacology	2002	51
Disposition and Metabolic Fate of Atomoxetine Hydrochloride: Pharmacokinetics, Metabolism, and Excretion in the Fischer 344 Rat and Beagle Dog Edward L. Mattiuz, G. Douglas Ponsler, Robert J. Barbuch, Drug Metabolism and Disposition	2003	51
Determination of olanzapine in human breast milk by high-performance liquid chromatography with electrochemical detection Stephen C. Kasper, Edward L. Mattiuz, Steven P. Swanson, Journal of Chromatography B Biomedical Sciences and Applications Human Breast MilkElectrochemical DetectionMedicineBioanalysisAnalytical Chemistry	1999	46
Olanzapine Transfer By Human Placenta S. Schenker, Yuxiao Yang, Edward L. Mattiuz, Clinical and Experimental Pharmacology and Physiology	1999	42
Olanzapine 10-N-glucuronide. A tertiary N-glucuronide unique to humans. Kelem Kassahun, Edward L. Mattiuz, Ronald B. Franklin, PubMed Psychotropic MedicationPsychopharmacologyPharmacotherapyTertiary N-glucuronide UniqueMolecular Pharmacology	1998	42

Page 1